American Cannabis News

Cannabis Stock Traders Care About MSOs Again – New Cannabis Ventures

Published

8 months ago

September 25, 2025

admin

You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number

Friends,

Every quarter, I refresh the Cannabis Stock Index, which covers active cannabis shares. The index returns at the end of 2012 and developed as the cannabis industry developed. I will share the full update next week, when Q3 is over, but I want to discuss a change in the index on the upcoming re-elexatization, which was based on data on 09/23.

The last quarter, I refreshed that the figure would again have 23 members, which is a typical type of shares. What surprised me about changes was that the MSOS in the index went down 6 to only 3. It is possible that the removal of its low trade in June may have been more shocking. 3 MSOS presented only 13% of the index at 6/30.

This next quarter, the number of shares, which qualifies 28, four new or returning members, are given to MSOS. Returning the indicator will be CRESCO LABS, CURALAF, TERRASCEND and VERANO HOLDINGS. On 7/30, on 7/30, 25% of the 7s index will be presented. Although MSOS’s share has sharply increased, this is not a high percentage. At the end of April 2024, only only only MSOS was 38% of the index when there were 11 MSOS 29.

I have constantly discussed how cannabels and investors can extend their concentration beyond only one part of the cannabis, so “only 25%” do not stand out to me. It’s the same percentage of what Canadian LPS is holding and it is inferior to 39% of assistance. MSOS has a great drawback because they trade on OTC, but they also face 280e taxation, which is combined with the debt of the balance sheet sheet.

The Rebalanced index will include all 5 of the largest MSOS, plus two people. The most interesting thing for me is what will not include. Of course, the heart is no longer in the figure, but there are several msos that are not yet in it, despite their mass income. The one who stands out is Vireo’s growth, which is not described due to its trading volume, which has not increased enough.

The growth of Varo first started trading in early 2019. For some time, it was an increase of kindness, but last summer became a virus. Originally, it was a medical canpian company based in Minnesota and operates in New York before I expanded Maryland. The company had to be united with the review, but the deal was distinguished and remained in court. Bengal Bengal Capital Josh Rosen joined as an interim executive director in early 2023 and became General Director in the summer of 2024 before leaving for October. The current CEO of the company, John Mazarakis, who joined Chicago Atlantic, at the end of 2024 as a company announced a big plan Buy 4 single state operators and collect $ 75 million for one share for $ 0.625. Company actually raised $ 81 millionA number of this was quite impressive.

There have been some people who are discussing Vireo growth, including multiple jacket Aaron Edelheit in many articles, as well as Pablo Zuanic. The company has already closed most of the achievements announced in December and caused $ 48 million, completing the quarter for $ 106 million in cash. Still, it seems that a lot of analyst does not seem coverage. In the past month, the shares on average made a daily trading shares that are lower than $ 400k minimum required.

Perhaps more disappointing than the lack of interest in investors has been the price of prices. At the end of 2024, the shares are currently kept by 10.7% when the company announced that it sold $ 81 million worth $ 0.625. MSOS gathered by 22%, and Cannabis Global Index has purchased 4.9% as of 9/25. Since the company announced transactions, it doubled at prices by 22% with MSOS. While the return of a year in MSOS is a lot, the vodge has been a little advanced.

Of course, Varo’s growth has seen a lot over the past few years. In 2023, it took the low level of all time, but the shares were falling since August. Cannabis investors should consider it. Big capital raising is underwater, and the volume of trade is small compared to the size of its actions.

Commercial volumes have expanded, especially for MSOS, and Varo’s growth has been transformed into itself. Investors, however, seem to be not yet. I continue to control the company’s evolution, but still do not include it in my focus of 19 shares. I want the growth of Viro to the best and hope that the buyers of his shares are approaching the end of the year, now 20%, do not stay in the red.

Frankly,

Alan

New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.

Exclusive

To get real-time updates follow Alan X.com:A number can also share and discover industry news along with sympathetic people, a large hemp group and entrepreneurship group ConnectionA number

Watch Revenue and Revenue Search Engine:which occupies the best income producing Cannabis shares.

Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number

Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email

Related Topics:Cannabis Care MSOs Stock Traders Ventures

Up Next

Verano Gets $75 Million Revolving Credit Line – New Cannabis Ventures

Don't Miss

Curaleaf’s Michigan Problem – New Cannabis Ventures

280E

Cannabis Stock Q1 Financial Reports Were Not the Story – New Cannabis Ventures

Published

7 days ago

May 15, 2026

admin

Cannabis Stock Q1 Financial Reports Were Not the Story – New Cannabis Ventures

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

Many more cannabis companies reported Q1 financials this week. While NCV did not run any of those press releases, all data has been updated in the New Cannabis Ventures Public Cannabis Company Revenue & Income Tracker. The largest companies reporting in US dollars all reported, and the eleven companies that reported for the Q1 ended in March (excluding Tilray Brands, which is due to report its Q4 later this month) saw an average year-over-year revenue increase of 31% in their cannabis businesses.

Excluding Vireo Growth, that average comes to -0.7%, which is lower, especially after accounting for inflation, and a sign of continued challenges for the hemp industry. Speaking of Vireo, I’ve pointed out how investors didn’t care, and they still don’t. An average of just 375,000 shares traded per day over the past month, and the stock, which closed at $0.415, continues to trade off the level of its late 2024 capital raise and the price at which the company issued shares to make multiple acquisitions.

April was a big month for hemp stocks, but prices fell in May. The NCV Global Cannabis Stock Index rose 8.8% to 5.70 in April, but fell 2.8% to 5.54 in May. The year-to-year change of this index, which now covers 23 stocks, was -15.9%. Since its peak in early 2021, the GCSI is down 94%. Many are excited about the medical cannabis realignment that took place in April, although it remains unclear whether cannabis will be completely overhauled. The Department of Justice will hold hearings in late June to discuss adult-use cannabis, and it could be. If so, 280E tax would be removed, and this would be very good. I’ve written a lot about this since late 2022 when I highlighted it The potential end of 280E as a major catalyst.

The investor base in cannabis stocks has shrunk due to capital losses and fewer people interested in the sector. Institutions were more interested in high prices and maybe they would enter the field. 280E remains a big story, and not only is it being delayed by the limited realignment that’s already been completed, it’s unclear how unpaid taxes from the last few years will be treated.

NCV has stopped publishing most cannabis news, although we continue to update the financial calendar as well as the earnings rankings. After more than 10 years with NCV and more than a dozen years with 420 Investor, I am in the process of moving on. This is probably the last weekly newsletter. I’ve appreciated sharing the news and my views here, and I want to wish everyone the best. Hopefully, 280E taxation will be fully completed and the bear market that began in early 2021 for the hemp sector will be over.

Sincerely,

Alan:

Contact us acquire NCV assets or a website domain

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we published last week.

Exclusives

Michigan cannabis sales are down again

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

aawh

Michigan Cannabis Sales Fell Yet Again – New Cannabis Ventures

Published

1 week ago

May 13, 2026

admin

Michigan Cannabis Sales Fell Yet Again – New Cannabis Ventures

Michigan April hemp sale decreased compared to a year ago, as they increased sequentially by 1.2%. At $258.6 million, sales decreased by 4.3 percent compared to last year.

Michigan’s cannabis regulatory agency breaks down sales by medical and adult use, with medical sales down 24.1% year-over-year to $0.4 million, down 5.6% sequentially, and adult-use sales down 4.3% year-over-year to $255.5 million, despite a one-day increase of 1.2% in March.

The state breaks down sales by category and provides pricing details by category for both medical and adult;

280E

Cannabis Stocks Are Going Nowhere Quickly – New Cannabis Ventures

Published

2 weeks ago

May 7, 2026

admin

Cannabis Stocks Are Going Nowhere Quickly – New Cannabis Ventures

friends,

The New Cannabis Ventures Global Cannabis Stock Index edged up slightly in May, rising 1.1% to 5.76. Compared to the previous year, it decreased by 12.6%. The index, recalculated as of the end of the first quarter, is up 9.9% so far in the second quarter, lagging the S&P 500’s 12.8% gain. Here are the earnings of the 23 names currently in the index (SMG was dropped in late April after the sale of Hawthorne Gardening):

MSOs are very much higher as the rally approaches the discussion of the big transformation announcements on 4/22 and beyond. There are currently six MSOs and two of them have been promoted. The rest rose, and the average of the six was 38.1%. The AdvisorShares Pure US Cannabis ETF ( MSOS ) has rallied 48.5% since the end of March and is now up 11.7% year-to-date in 2026. Both GCSI names have fallen sharply, and the index has a total of seven double-digit gains in Q2, with six MSOs and Canopy holding investments. 14 of the 23 names returned less than GCSI.

As readers are probably aware, the US reclassified medical cannabis from Schedule I to Schedule III on 4/23, and that will go away. 280E tax for some of the businesses of cannabis companies. The Department of Justice will hold a hearing in late June to determine possible rezoning for adult use. If it passes, all 280E taxation will end, which is a good thing for cannabis companies and their investors, as well as the subsidiaries that serve them. It is not yet known what the outcome will be, and it is not yet known how past 280E taxes that have not been paid but are carried as liabilities (and not debt) will be handled. Also, there is no conclusion yet on SECURITY banking or the possibility of a raise.

NCV has stopped publishing news, although we continue to update the financial calendar as well as the earnings rankings. After more than 10 years with NCV and more than a dozen years with 420 Investor, I am in the process of moving on. I’ve appreciated sharing the news and my views here, and I want to wish everyone the best. Hopefully, the 280E taxation will end and the bear market that started in early 2021 for the hemp sector will come to an end.

Sincerely,

Alan:

This week’s newsletter is sponsored by the Paul E. Saperstein Co.

Massachusetts hemp production equipment for sale

On May 12, Middlesex Integrative Medicine, Inc.’s equipment is being auctioned online in Leominster, Massachusetts at 10:00 a.m. ET. All applications must be submitted online. Learn more Of the secured party’s sale of all assets of this cultivation equipment.

Interested parties may contact Paul Cotto at 617-227-6553 or email pcotto@pesco.com:.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.

Exclusives

Sales of Canadian hemp continued in February

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.